ATS 2024 Final Program

Click on the session title to view the speakers

144

MONDAY • MAY 20

P1442 Nasal Patency Is Not Affected by Nasal High Flow Applied With a Symmetrical or Asymmetrical Cannula Interface P1443 Humidity Output of a Novel High Flow Oxygen Therapy Device P1444 Effective Flow Rates and Decarboxylation Differs Between Nasal High-flow Devices P1445 Right Ventriculoarterial Coupling During Positive End-expiratory Pressure Titration Based on a Pressure-based Single Beat Method: A Proof-of-Concept Study P1446 Partitioned Respiratory Mechanics in Two Different Models of Obesity Phenotype

P970 Risk of Prolonged Mechanical Ventilation With COVID-19 Varies by Strain P971 Long-term Mortality After SARS-CoV-2 Hospitalization: A Real World Analysis P972 The Prognostic Value of PaO2/FiO2 Ratio in Predicting Clinical Outcomes in COVID-19 Patients P973 Identification and Validation of Respiratory Subphenotypes in Patients With COVID-19 Acute Respiratory Distress Syndrome Undergoing Prone Position P974 Nucleated Red Blood Cells as a Prognostic Marker for Mortality in Patients With COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS): An Observational Study P975 Neutrophil-to-Lymphocyte Ratio Value and Its Relationship With Outcome in COVID-19 Patients P976 Serial Biomarker Measurements May Be Helpful to Predict the Successful Application of High Flow Nasal Cannula (HFNC) in COVID-19 Pneumonia P978 Association Between Endothelial Activation and P979 Association of Co-infections With Outcomes Across COVID-19 Variants P980 The Impact of the COVID-19 Pandemic on P981 Morbidity and Mortality of COVID-influenza Coinfection in a Large Academic Healthcare System P982 Clinical Characteristics of Bloodstream Infections in Critically Ill COVID-19 Patients on Mechanical Ventilation: A Multicenter Cohort Study P983 Impact of Staphylococcus Aureus Co-infection on Creatine Kinase and Severity Scores in COVID-19 P984 Bronchoscopy Utilization in Medical Intensive Care Unit During the COVID-19 Surges P985 Pneumomediastinum in COVID-19: Assessment of Treatment Modalities P986 Impact of Pneumothorax on Mortality, Morbidity, Antimicrobial Resistance in Central Line Infections Stress Index (EASIX) and Intensive Care Unit (ICU) Mortality in Critically Ill COVID-19 Patients Admitted to ICU: A Nationwide Retrospective Multicenter Cohort Study

CLINICAL • TRANSLATIONAL THEMATIC POSTER SESSION

B40 COVID-19 EPIDEMIOLOGY IN 2024 9:15 a.m. - 4:15 p.m.

San Diego Convention Center Area I (Hall H, Ground Level)

Viewing: Posters will be on display for entire session Discussion: 11:30-12:30 Discussionwith facilitators, authors, andattendees 12:30-1:15 Authorswill beby their posters for individual discussionwithattendees P964 Increased Mechanical Ventilation and Mortality Among Ethnic Minority Patients With COVID-19 in Hawai’i P965 The Relationship of COVID-19 Vaccination With Mechanical Ventilation and Mortality Among 7,365 Hospitalized Patients in Hawai’i P966 Examining Temporal Variations in Sepsis-related Hospitalizations and Mortality: A Comprehensive Analysis of NIS Database (2018-2020) P967 Impact of Hispanic Ethnicity on Mortality Rates in Mechanically Ventilated Patients P968 Evolution of the Number of Appointments, Hospitalizations, and Mortality Due to COVID-19 From 2020 to 2022 in a Regional Brazilian Unit

P969 Outcomes of Immunocompromised and

and Hospital Resource Utilization in COVID-19 Patients: A Propensity Matched Analysis From Nationwide Inpatient Sample

Non-immunocompromised Patients in the Intensive Care Unit Differ Depending on COVID Strain

ATS 2024 Conference Program • San Diego, CA